Urine-Based Tumor DNA Test May Help Personalize Bladder Cancer Treatment

Urine-based tumor DNA test may help personalize bladder cancer treatment

In a multi-institutional study published in the European Urology journal, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment.

Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer

A groundbreaking multi-institutional study has unveiled a promising approach to improving the management of bladder cancer by utilizing urine-based tumor DNA (utDNA) analysis. Published in the prestigious journal European Urology, the research highlights how quantifying utDNA can predict the risk of recurrence in patients undergoing immunotherapy, specifically those treated with atezolizumab. This advance heralds a new era in personalized bladde…